Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 1548 · · 10 pages · English
Summary by 6ix AI
It reports on the movements in authorized and registered share capital, as well as issued shares and treasury shares. The document confirms compliance with public float requirements and provides details on share options exercised during the month. Overall, the filing indicates an increase in issued shares and confirms the sufficiency of public float.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Genscript Biotech Corporation on 6ix
Earlier from Genscript Biotech
- Change in board lot size
- Announcement pursuant to rule 13.10 of the listing rules
- List of directors and their role and function
- Passing away of an independent non-executive director and change in composition of board committees
- Interim report 2026
Later from Genscript Biotech
All Genscript Biotech news releasesFollow Genscript Biotech into a list and get an email when it puts out news.
Follow Genscript Biotech